Novo Nordisk (NYSE:NVO) reported quarterly earnings of $0.96 per share which beat the analyst consensus estimate of $0.81 by 18.52 percent. This is a 5.49 percent increase over earnings of $0.91 per share from the same period last year. The company reported quarterly sales of $12.209 billion which beat the analyst consensus estimate of $11.350 billion by 7.57 percent. This is a 4.55 percent increase over sales of $11.678 billion the same period last year.